天乐园古参堂：资质达标实力过硬，契合上市核心条件

Group 1 - The company, Gucantang, has met the basic compliance requirements for the listing process, including legal existence for over three years, stable main business operations, and no significant changes in core management [1] - Financially, Gucantang can adapt to different listing board requirements, such as exceeding a cumulative net profit of 30 million yuan for the A-share market, or opting for the Hong Kong 18A board which allows exemption from profit-related requirements [1] Group 2 - Gucantang has established a technological competitive edge with patented enzyme conversion technology, which has won a national technology invention award, and its industrial application capability is maturing, providing core support for its capital market ambitions [3] - The company has built a complete independent production, procurement, and sales system, demonstrating a clear and traceable profit logic, with indicators like improved technology conversion efficiency and stable product repurchase rates reflecting a healthy operational trend [3] - Gucantang's breakthroughs in the production of rare ginsenoside Rh2 through enzyme conversion not only advance industry development but also enhance its listing prospects, as companies with high purity and compliance qualifications are more likely to meet listing review requirements [3]